LSA
SRNE

Leonteq Securities AG’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Leonteq Securities AG’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,000
Closed -$6.28K – 1396
2022
Q3 		$6.28K Hold
4,000
– – ﹤0.01% 1112
2022
Q2 		$8.04K Buy
4,000
+2,000
+100% +$3.46K ﹤0.01% 1115
2022
Q1 		$4.66K Buy
2,000
+1,000
+100% +$3.12K ﹤0.01% 1168
2021
Q4 		$4.65K Sell
1,000
-2,000
-67% -$12.4K ﹤0.01% 1190
2021
Q3 		$22.9K Buy
3,000
+1,000
+50% +$8.48K ﹤0.01% 956
2021
Q2 		$19.4K Sell
2,000
-3,000
-60% -$23.9K ﹤0.01% 950
2021
Q1 		$41.4K Buy
+5,000
New +$52.8K ﹤0.01% 806

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM